title: Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.
abstract: The Versant HCV genotype 2.0 assay (line probe assay [LiPA] 2.0), based on reverse hybridization, and the Abbott Realtime HCV genotype II assay (Realtime II), based on genotype-specific real-time PCR, have been widely used to analyze hepatitis C virus (HCV) genotypes. However, their performances for detecting HCV genotype 6 infections have not been well studied. Here, we analyzed genotype 6 in 63 samples from the China HCV Genotyping Study that were originally identified as genotype 6 using the LiPA 2.0. The genotyping results were confirmed by nonstructural 5B (NS5B) or core sequence phylogenetic analysis. A total of 57 samples were confirmed to be genotype 6 (51 genotype 6a, 5 genotype 6n, and 1 genotype 6e). Four samples identified as a mixture of genotypes 6 and 4 by the LiPA 2.0 were confirmed to be genotype 3b. The remaining two samples classified as genotype 6 by the LiPA 2.0 were confirmed to be genotype 1b, which were intergenotypic recombinants and excluded from further comparison. In 57 genotype 6 samples detected using the Realtime II version 2.00 assay, 47 genotype 6a samples were identified as genotype 6, one 6e sample was misclassified as genotype 1, and four 6a and five 6n samples yielded indeterminate results. Nine nucleotide profiles in the 5' untranslated region affected the performances of both assays. Therefore, our analysis shows that both assays have limitations in identifying HCV genotype 6. The LiPA 2.0 cannot distinguish some 3b samples from genotype 6 samples. The Realtime II assay fails to identify some 6a and all non-6a subtypes, and it misclassifies genotype 6e as genotype 1.
authors.affiliation: Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
authors.forename: Ruifeng
authors.initials: R
authors.lastname: Yang
authors.affiliation: Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
authors.forename: Xu
authors.initials: X
authors.lastname: Cong
authors.affiliation: Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
authors.forename: Shaocai
authors.initials: S
authors.lastname: Du
authors.affiliation: Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
authors.forename: Ran
authors.initials: R
authors.lastname: Fei
authors.affiliation: Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
authors.forename: Huiying
authors.initials: H
authors.lastname: Rao
authors.affiliation: Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China weilai@pkuph.edu.cn.
authors.forename: Lai
authors.initials: L
authors.lastname: Wei
mesh_terms: D002681:China; D003951:Diagnostic Errors; D005838:Genotype; D060005:Genotyping Techniques / Q000379:methods*; D016174:Hepacivirus / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification*; D006526:Hepatitis C / Q000175:diagnosis* / Q000821:virology*; D006801:Humans; D009693:Nucleic Acid Hybridization / Q000379:methods; D060888:Real-Time Polymerase Chain Reaction / Q000379:methods
references.citation: Intervirology. 2006;49(4):224-9
references.pmid: 16491017
references.citation: J Med Virol. 2013 May;85(5):815-22
references.pmid: 23508907
references.citation: J Med Virol. 2010 Feb;82(2):257-62
references.pmid: 20029811
references.citation: Science. 2001 Jun 22;292(5525):2323-5
references.pmid: 11423661
references.citation: Gastroenterology. 2014 May;146(5):1145-50.e1-4
references.pmid: 24662488
references.citation: Eur J Epidemiol. 1998 Jul;14(5):421-6
references.pmid: 9744672
references.citation: J Clin Microbiol. 2007 Apr;45(4):1102-12
references.pmid: 17287328
references.citation: J Med Virol. 2006 May;78(5):574-81
references.pmid: 16555294
references.citation: Pathol Biol (Paris). 2010 Apr;58(2):175-8
references.pmid: 19942365
references.citation: J Hepatol. 2011 Aug;55(2):245-64
references.pmid: 21371579
references.citation: J Clin Microbiol. 2006 Nov;44(11):3969-74
references.pmid: 16957039
references.citation: Hepatol Res. 2007 May;37(5):337-45
references.pmid: 17441806
references.citation: J Gastroenterol Hepatol. 2014 Mar;29(3):545-53
references.pmid: 24090188
references.citation: J Antimicrob Chemother. 2011 Aug;66(8):1673-86
references.pmid: 21652618
references.citation: J Clin Microbiol. 2008 Jun;46(6):1901-6
references.pmid: 18400913
references.citation: J Clin Microbiol. 2005 Feb;43(2):733-9
references.pmid: 15695672
references.citation: J Gen Virol. 1995 Jul;76 ( Pt 7):1749-61
references.pmid: 9049380
references.citation: J Clin Virol. 2013 Sep;58(1):249-53
references.pmid: 23731847
references.citation: J Hepatol. 2013 Mar;58(3):445-51
references.pmid: 23142061
references.citation: Clin Chem Lab Med. 2010 Apr;48(4):469-74
references.pmid: 20128734
references.citation: Gastroenterology. 2006 Aug;131(2):478-84
references.pmid: 16890602
references.citation: Hepatology. 2014 Jan;59(1):318-27
references.pmid: 24115039
references.citation: J Gen Virol. 1995 Oct;76 ( Pt 10):2493-507
references.pmid: 7595353
references.citation: J Gen Virol. 1993 Nov;74 ( Pt 11):2391-9
references.pmid: 8245854
references.citation: N Engl J Med. 2013 May 16;368(20):1878-87
references.pmid: 23607594
references.citation: Int J Mol Med. 2013 Feb;31(2):347-52
references.pmid: 23241873
references.citation: J Virol Methods. 2010 Aug;167(2):205-7
references.pmid: 20362009
references.citation: J Virol. 2014 Jul;88(13):7120-9
references.pmid: 24719413
references.citation: J Virol Methods. 2003 May;109(2):187-93
references.pmid: 12711062
references.citation: J Gen Virol. 1992 May;73 ( Pt 5):1131-41
references.pmid: 1316939
references.citation: J Clin Microbiol. 1999 Aug;37(8):2625-30
references.pmid: 10405412
references.citation: J Hepatol. 2012 Jun;56(6):1247-53
references.pmid: 22326470
references.citation: J Virol Methods. 2003 May;109(2):195-201
references.pmid: 12711063
references.citation: J Gen Virol. 1994 May;75 ( Pt 5):1053-61
references.pmid: 8176367
references.citation: J Clin Microbiol. 2013 Sep;51(9):2815-21
references.pmid: 23616453
references.citation: J Virol. 2006 Aug;80(15):7569-77
references.pmid: 16840336
references.citation: Jpn J Infect Dis. 2011;64(6):537-9
references.pmid: 22116339
references.citation: Hepatology. 2006 Nov;44(5):1355-61
references.pmid: 17058236
references.citation: J Hepatol. 2012 May;56(5):1012-1018
references.pmid: 22266603
references.citation: J Clin Microbiol. 1996 Sep;34(9):2259-66
references.pmid: 8862595
references.citation: Jpn J Exp Med. 1990 Aug;60(4):215-22
references.pmid: 1963453
references.citation: Lancet. 1990 Oct 6;336(8719):878-9
references.pmid: 1976900
references.citation: Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Dec 18;38(6):614-7
references.pmid: 17173082